These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10523177)

  • 1. Cancer research. A new way to combat therapy side effects.
    Ferber D
    Science; 1999 Sep; 285(5434):1651, 1653. PubMed ID: 10523177
    [No Abstract]   [Full Text] [Related]  

  • 2. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy.
    Komarov PG; Komarova EA; Kondratov RV; Christov-Tselkov K; Coon JS; Chernov MV; Gudkov AV
    Science; 1999 Sep; 285(5434):1733-7. PubMed ID: 10481009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [PFTalpha, guardian of the sick?].
    Jacquemin-Sablon A
    Bull Cancer; 1999 Nov; 86(11):894-5. PubMed ID: 10627130
    [No Abstract]   [Full Text] [Related]  

  • 4. [A chemical inhibitor of p53 that protects mice from the side effects of cancer treatment].
    Stadler P; Grosu AL; Molls M
    Strahlenther Onkol; 2000 Feb; 176(2):98. PubMed ID: 10697660
    [No Abstract]   [Full Text] [Related]  

  • 5. Small-molecule inhibitor of p53 binding to mitochondria protects mice from gamma radiation.
    Strom E; Sathe S; Komarov PG; Chernova OB; Pavlovska I; Shyshynova I; Bosykh DA; Burdelya LG; Macklis RM; Skaliter R; Komarova EA; Gudkov AV
    Nat Chem Biol; 2006 Sep; 2(9):474-9. PubMed ID: 16862141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of p53: a new approach to overcome side effects of antitumor therapy.
    Komarova EA; Gudkov AV
    Biochemistry (Mosc); 2000 Jan; 65(1):41-8. PubMed ID: 10702639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pifithrin-alpha promotes p53-mediated apoptosis in JB6 cells.
    Kaji A; Zhang Y; Nomura M; Bode AM; Ma WY; She QB; Dong Z
    Mol Carcinog; 2003 Jul; 37(3):138-48. PubMed ID: 12884365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents.
    Mahyar-Roemer M; Roemer K
    Oncogene; 2001 Jun; 20(26):3387-98. PubMed ID: 11423989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of p53-induced apoptosis in cerebral ischemia: effects of the p53 inhibitor pifithrin alpha.
    Leker RR; Aharonowiz M; Greig NH; Ovadia H
    Exp Neurol; 2004 Jun; 187(2):478-86. PubMed ID: 15144874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of apoptosis in lymphocytes: synthesis and biological evaluation of compounds related to pifithrin-alpha.
    Barchéchath SD; Tawatao RI; Corr M; Carson DA; Cottam HB
    J Med Chem; 2005 Oct; 48(20):6409-22. PubMed ID: 16190767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective therapeutic applications of p53 inhibitors.
    Gudkov AV; Komarova EA
    Biochem Biophys Res Commun; 2005 Jun; 331(3):726-36. PubMed ID: 15865929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imino-tetrahydro-benzothiazole derivatives as p53 inhibitors: discovery of a highly potent in vivo inhibitor and its action mechanism.
    Pietrancosta N; Moumen A; Dono R; Lingor P; Planchamp V; Lamballe F; Bähr M; Kraus JL; Maina F
    J Med Chem; 2006 Jun; 49(12):3645-52. PubMed ID: 16759106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual effect of p53 on radiation sensitivity in vivo: p53 promotes hematopoietic injury, but protects from gastro-intestinal syndrome in mice.
    Komarova EA; Kondratov RV; Wang K; Christov K; Golovkina TV; Goldblum JR; Gudkov AV
    Oncogene; 2004 Apr; 23(19):3265-71. PubMed ID: 15064735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The p53 inhibitor pifithrin-alpha is a potent agonist of the aryl hydrocarbon receptor.
    Hoagland MS; Hoagland EM; Swanson HI
    J Pharmacol Exp Ther; 2005 Aug; 314(2):603-10. PubMed ID: 15843497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitization of cervical cancer cell lines to low-dose radiation by retinoic acid does not require functional p53.
    Tillmanns TD; Kamelle SA; Guruswamy S; Gould NS; Rutledge TL; Benbrook DM
    Gynecol Oncol; 2005 Apr; 97(1):142-50. PubMed ID: 15790450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of P53-related apoptosis had no effect on PrP(Sc) accumulation and prion disease incubation time.
    Engelstein R; Grigoriadis N; Greig NH; Ovadia H; Gabizon R
    Neurobiol Dis; 2005 Mar; 18(2):282-5. PubMed ID: 15686956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamin-2 regulates oxidized low-density lipoprotein-induced apoptosis of vascular smooth muscle cell.
    Kashiwakura Y; Watanabe M; Kusumi N; Sumiyoshi K; Nasu Y; Yamada H; Sawamura T; Kumon H; Takei K; Daida H
    Circulation; 2004 Nov; 110(21):3329-34. PubMed ID: 15545517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of tumor suppressor p53 decreases PTEN expression and enhances signaling pathways leading to activation of activator protein 1 and nuclear factor kappaB induced by UV radiation.
    Wang J; Ouyang W; Li J; Wei L; Ma Q; Zhang Z; Tong Q; He J; Huang C
    Cancer Res; 2005 Aug; 65(15):6601-11. PubMed ID: 16061640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of p53 protects liver tissue against endotoxin-induced apoptotic and necrotic cell death.
    Schäfer T; Scheuer C; Roemer K; Menger MD; Vollmar B
    FASEB J; 2003 Apr; 17(6):660-7. PubMed ID: 12665479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of p53 response in tumor stroma improves efficacy of anticancer treatment by increasing antiangiogenic effects of chemotherapy and radiotherapy in mice.
    Burdelya LG; Komarova EA; Hill JE; Browder T; Tararova ND; Mavrakis L; DiCorleto PE; Folkman J; Gudkov AV
    Cancer Res; 2006 Oct; 66(19):9356-61. PubMed ID: 17018587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.